Test C

• Hypopituitarism
• Symptoms of male climax (decreased libido and physical and intellectual activity)
• Post castration syndrome (androgenic deficit after castrating)
• Osteoporosis caused by androgen insufficiency
• Retaining sexual maturation
• Eunuchoidism, undeveloped genitals
• Impotence hormonal origin
• Endometriosis (in women)
• The menopause (in combination with estrogen)
• Breast cancer (in women)
• Osteoporosis (in women)
• Hiperestrogenemia, functional hemorrhage
• Uterine myoma

• Sensitivity to the medicine
• Prostate related or breast cancer
• Prostate hypertrophy with urinary system disorders
• Nephrotic or nephrotic stage of nephritis
• Edema, hypercalcemia
• Hepatic dysfunction, diabetes
• Coronary heart disease, myocardial infarct in medical history
• Atherosclerosis in older males
• Pregnancy, breastfeeding

Testosterone cypionate is administered intramuscularly. The optimal dose for adults is 50-200 mg administered intramuscularly once a week. During therapy, one must not exceed 400 mg per month. In hypogonadal men with eunuchoidism: 50-400 mg every 2-4 weeks. For sexual maturation retention: 50-200 mg every 2-4 weeks for 4-6 months. For inoperable breast cancer in women: 200-400 mg every 2-4 weeks. This medicine must not be administered intravenously!

Testosterone is the main hormone released by the testicles. It's responsible for the growth of male sex features and extra sexual parts (prostate gland, seminal vesicles, penis and scrotum), man hair distribution (face, pubis, chest) developing laryngeal muscles and body fat distribution. Contains nitrogen, sodium, potassium, and phosphorus, raises proteins anabolism minimizing catabolism. Rapid increase plasma levels of androgenic hormone with testosterone in prepubertal leads to slower growth and long bone closure.